Categories: News

Creative Science’s Microchip Brand, BuddyID, Offers Free Lifetime Registration for Pets Affected by Save This Life Microchip Registry Shutdown

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ORANGE CITY, Iowa, Feb. 18, 2025 /PRNewswire/ — Creative Science®, a leader in animal health solutions, is stepping up to support pet owners, veterinary clinics, and shelters affected by the recent shutdown of the Save This Life (STL) pet microchip registry. Through its trusted microchip and recovery brand, BuddyID®, Creative Science is offering free lifetime registration for all pets with impacted STL microchips, ensuring they remain protected in the event they go missing.

As part of this initiative, Creative Science is also extending free registration to any remaining Save This Life microchips still in possession of veterinary clinics and shelters. By transitioning these microchips into the BuddyID registry, animal care professionals can continue providing reliable pet identification and reunification services without disruption.

“Ensuring lost pets can always find their way home is at the heart of what we do,” said Charlie Passantino, President of Creative Science. “The shutdown of Save This Life’s registry left many pet owners and clinics in a difficult situation, and we want to provide a seamless solution by welcoming these microchips into our network at no cost.”

BuddyID has been a trusted name in microchip identification and lost pet recovery for over 30 years. The brand’s comprehensive system includes a global pet registry, innovative temperature-sensing microchips, and the BuddyBadge® QR Collar Tag, which provides instant access to pet recovery information. This initiative reflects Creative Science’s ongoing commitment to ensuring every pet has a secure and reliable means of identification.

Pet owners, veterinary clinics, and shelters with STL microchips are encouraged to call 800-434-2843 or email help@buddyid.com for assistance with free registration. Additionally, veterinary clinics and shelters that choose to move their remaining STL chips to the BuddyID registry will receive 25 complimentary BuddyID ISO Microchip + Temp chips if done by March 31st. Contact BuddyID for more information.

About Creative Science
Creative Science is a leading provider of innovative solutions in the veterinary and animal health industries. Formed through the merger of several trusted veterinary brands, Creative Science is committed to bridging gaps in animal care with high-quality products and services designed to enhance pet well-being and veterinary practice efficiency.

View original content to download multimedia:https://www.prnewswire.com/news-releases/creative-sciences-microchip-brand-buddyid-offers-free-lifetime-registration-for-pets-affected-by-save-this-life-microchip-registry-shutdown-302379132.html

SOURCE Creative Science

Staff

Recent Posts

BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market

Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or…

2 hours ago

Dr. Lyudmila Sarder Receives Prestigious U.S. Congressional Award for Women’s History Month

"Trailblazing Physician and Advocate Receives U.S. Congressional Award for Advancing Healthcare Access and Community Service…

2 hours ago

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™…

2 hours ago

Relmada Therapeutics to Report Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025

CORAL GABLES, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”,…

2 hours ago

Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider

Oslo, Norway, 26 March, 2025 Reference is made to the stock exchange notice published by…

2 hours ago

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE…

2 hours ago